Skip to main content

Table 2 Comparison between both groups of patients regarding baseline laboratory variables and infarction site as well as admission NIHSS score

From: Troponin-I elevation predicts outcome after thrombolysis in ischemic stroke patients

Variable

Group 1

Group 2

P value

13 (18%)

59 (82%)

Laboratory variables

Hemoglobin (g/dL)

12.6 ± 1.8

12.7 ± 1.4

0.21

White blood cell (× 103/μl)

9.5 ± 2.3

9.2 ± 3.6

0.43

Platelet (× 103/μl)

268.7 ± 82.6

249.3 ± 75.4

0.41

Creatinine (mg/dL)

0.80 ± 0.20

0.78 ± 0.20

0.74

Total cholesterol (mg/dl)

187.6 ± 31.4

178.5 ± 51.1

0.54

Triglyceride (mg/dl)

138.9 ± 76.2

127.9 ± 62.42

0.58

Aspartate transaminase (U/L)

20.18 ± 7.82

20.16 ± 4.84

0.99

Alanine aminotransferase (U/L)

12.19 ± 8.81

13. 91 ± 7.08

0.45

HDL-C (mg/dl)

31.5 ± 7.3

39.6 ± 12.4

0.02*

LDL-C (mg/dl)

106.4 ± 32.1

102.4 ± 29.1

0.66

Fasting glucose (mg/dL)

149.9 ± 65.6

154.9 ± 51.9

0.54

PT on admission (s)

13.9 ± 3.2

12.0 ± 7.1

0.35

INR on admission

1.12 ± 0.27

1.11 ± 0.25

0.89

APTT on admission (s)

27.0 ± 6.10

25.8 ± 6.90

0.56

Infarction site

Anterior cerebral circulation, n (%)

6 (46)%

28 (47%)

0.93

Posterior cerebral circulation, n (%)

7 (54%)

31 (53%)

Admission NIHSS score

12.5 ± 9.4

7.2 ± 6.2

0.01*

  1. Continuous data are represented in mean ± SD; categorical data are represented in number and percentage
  2. Group 1, patients with elevated admission serum troponin-I level; group 2, patients without elevated admission serum troponin-I level
  3. HDL-C High density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, APTT Activated partial thromboplastin time, PT Prothrombin time, NIHSS National Institute of Health Stroke Scale
  4. *Significant P < 0.05